Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Quest Diagnostics ( DGX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 1.0%. By the end of trading, Quest Diagnostics rose $3.05 (5.5%) to $57.99 on heavy volume. Throughout the day, 6,882,301 shares of Quest Diagnostics exchanged hands as compared to its average daily volume of 2,444,200 shares. The stock ranged in a price between $56.99-$60.50 after having opened the day at $58.50 as compared to the previous trading day's close of $54.94. Other companies within the Health Services industry that increased today were: IsoRay ( ISR), up 12.6%, China Cord Blood ( CO), up 5.7%, Oculus Innovative ( OCLS), up 5.5% and Tenet Healthcare ( THC), up 5.2%.

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. Quest Diagnostics has a market cap of $8.0 billion and is part of the health care sector. Shares are up 2.6% year to date as of the close of trading on Tuesday. Currently there are 2 analysts that rate Quest Diagnostics a buy, 4 analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Quest Diagnostics as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, notable return on equity, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Hooper Holmes ( HH), down 11.3%, IMRIS ( IMRS), down 8.4%, Cardica ( CRDC), down 8.0% and Health Insurance Innovations ( HIIQ), down 7.9% , were all laggards within the health services industry with Humana ( HUM) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.